IR-Med, Inc. Files 8-K: Agreements, Equity Sales, Officer Changes
Ticker: IRME · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1839133
| Field | Detail |
|---|---|
| Company | Ir-Med, Inc. (IRME) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, officer-changes, director-changes
TL;DR
IR-Med, Inc. dropped an 8-K: new deals, stock sales, and exec shake-ups. Watch this space.
AI Summary
On March 26, 2025, IR-Med, Inc. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, unregistered sales of equity securities, and changes in directors and officers, including compensatory arrangements. The filing also covers financial statements and exhibits related to these events.
Why It Matters
This 8-K filing signals significant corporate actions at IR-Med, Inc., including potential new business agreements and changes in its leadership structure, which could impact its future operations and stock performance.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- IR-Med, Inc. (company) — Filer of the 8-K report
- March 26, 2025 (date) — Date of the earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 000-56492 (file_number) — SEC File Number
- 84-4516398 (ein) — IRS Employer Identification Number
FAQ
What type of material definitive agreement did IR-Med, Inc. enter into?
The filing indicates IR-Med, Inc. entered into a material definitive agreement, but the specific details of this agreement are not provided in the summary information.
What were the details of the unregistered sales of equity securities?
The 8-K report mentions unregistered sales of equity securities, but the specific number of shares, price, or purchasers are not detailed in the provided summary.
Were there any changes in IR-Med, Inc.'s board of directors or executive officers?
Yes, the filing notes the departure of directors or certain officers, the election of directors, and the appointment of certain officers, along with compensatory arrangements.
What is the significance of the 'Financial Statements and Exhibits' mentioned in the filing?
The inclusion of financial statements and exhibits suggests that supporting documentation for the reported events, such as agreements or transactions, is being provided with the filing.
What was IR-Med, Inc.'s former company name?
IR-Med, Inc.'s former company name was International Display Advertising, Inc., with a date of name change on January 5, 2021.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding IR-Med, Inc. (IRME).